Incomplete paralog compensation generates selective dependency on TRA2A in cancer.

Area of Science:

• Molecular Biology
• Cancer Biology
• Genetics

Background:

• Paralogs provide functional redundancy, compensating for each other's loss.
• This compensatory mechanism is often lost in cancer, creating vulnerabilities.
• Splicing factors play crucial roles in gene expression regulation.

Purpose of the Study:

• To investigate the functional relationship between splicing factors TRA2A and TRA2B.
• To identify cancer-specific dependencies related to paralogous splicing factors.
• To understand the role of paralog buffering in cancer cell survival.

Main Methods:

• Comparative analysis of TRA2A and TRA2B function in splicing.
• Depletion studies of TRA2A in cancer cell lines.
• Assessment of splicing defects, mitotic errors, and cell viability.
• Overexpression studies of TRA2B to rescue TRA2A loss phenotypes.

Main Results:

• TRA2A and TRA2B are redundant activators of alternative and constitutive splicing.
• A subset of cancer cells exhibit dependency on TRA2A due to impaired paralog buffering.
• TRA2A depletion in these cells leads to splicing defects, mitotic failure, and cell death.
• TRA2B overexpression rescues TRA2A loss phenotypes, demonstrating dosage sensitivity.

Conclusions:

• Dysfunctional paralog buffering in cancer creates selective dependencies on splicing factors like TRA2A.
• The dosage-dependent relationship between TRA2A and TRA2B highlights a novel vulnerability in cancer.
• Targeting TRA2A or restoring TRA2B function could be potential therapeutic strategies.